Tinabinol

Tinabinol
Clinical data
ATC code	None;
Identifiers
	IUPAC name 5,5-dimethyl-8-(3-methyl-2-octanyl)-1,2,3,5-tetrahydrothiopyrano[2,3-c]chromen-10-ol;
CAS Number	50708-95-7;
PubChem CID	65443;
ChemSpider	58905;
UNII	455Y914AKK;
Chemical and physical data
Formula	C23H34O2S
Molar mass	374.58 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O3c1cc(cc(O)c1\C2=C(\SCCC2)C3(C)C)C(C)C(C)CCCCC;
	InChI InChI=1S/C23H34O2S/c1-6-7-8-10-15(2)16(3)17-13-19(24)21-18-11-9-12-26-22(18)23(4,5)25-20(21)14-17/h13-16,24H,6-12H2,1-5H3; Key:YCNTYPIGYVTFBO-UHFFFAOYSA-N;

Tinabinol (INN; SP-119) is a synthetic cannabinoid drug and analogue of dronabinol and dimethylheptylpyran which was patented as an antihypertensive but was never marketed.^[1]^[2]

References

↑ Brown DT (19 November 1998). Cannabis: The Genus Cannabis. CRC Press. p. 80. ISBN 978-90-5702-291-3. Retrieved 27 April 2012.
↑ Negwer M (1994). Organic-chemical drugs and their synonyms: an international survey. Indices. Akad.-Verl. p. 2242. ISBN 978-3-05-501629-5. Retrieved 27 April 2012.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.